India's Metropolis Healthcare rises on pathology laboratory acquisition
** Shares of Metropolis Healthcare METP.NS rise 3.1% to 2,111 rupees ** Co acquires competitor Ambika Pathology Laboratory; deal value undisclosed ** METP set to rise after falling for two straight sessions ** YTD, METP down 1.4% ($1 = 88.2880 Indian rupees) (Reporting by Yagnoseni Das in Bengaluru) ((Yagnoseni.Das@thomsonreuters.com;))
Recent news on Metropolis Healthcare
See all newsBrief: Metropolis Healthcare Q2fy27 Revenue Grew About 15% Year-On-Year
Brief: Metropolis Health Says Unit Metropolis Quality Solutions Enters Share Subscription And Shareholder's Agreements
Brief: Metropolis Health June-Quarter Consol Net Profit 566.7 Million Rupees
Brief: Metropolis Health Declares 2Nd Interim Dividend Of 1 Rupee Per Share
Brief: Metropolis Health March-Quarter Consol Net Profit 509 Million Rupees